Brain damage caused by dementia can lead to anxiety, fear, and irritability, especially in the evening. This is how ...

Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...

Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...

There are treatments to stave off Alzheimer's effects if caught early enough - and there are some red flags people should ...

Scientists have discovered that inhaling xenon gas activates brain immune cells to break down Alzheimer 's-related plaques ...

Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

Many of our scientists are focussed on developing treatments that can slow down or stop the diseases that cause dementia. This work is vital, as currently there are no drugs available on the NHS that ...

And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...